Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estimation of Liver Fibrosis in Patients With MASLD Screening Criteria Through Endoscopic Ultrasound-guided Shear Wave vs Transabdominal Ultrasound and Transient Elastography: The RUMIPAMBA Diagnostic Trial

NCT06102980 is registered in ClinicalTrials.gov with Instituto Ecuatoriano de Enfermedades Digestivas as lead sponsor.

NCT NCT06102980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06102980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estimation of Liver Fibrosis in Patients With MASLD Screening Criteria Through Endoscopic Ultrasound-guided Shear Wave vs Transabdominal Ultrasound and Transient Elastography: The RUMIPAMBA Diagnostic Trial
Lead sponsor
Instituto Ecuatoriano de Enfermedades Digestivas
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2023
Completion date
April 1, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, liver, liver steatosis